p.124 抽出テキスト

before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 1593–1599. PMID: 14506118 448. Kofoed KF, Kelbæk H, Hansen RP, et al. Early Versus Standard Care Invasive Examination and Treatment of Patients with Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial. Circulation 2018; 138: 2741–2750. 449. 日本循環器学会. 2017-2018 年度活動: 冠動脈血行再建ガイドライン(2018 年改訂版).http://www.j-circ.or.jp/guideline/pdf/ JCS2018_nakamura_yaku.pdf 450. Bangalore S, Faxon DP. Coronary intervention in patients with acute coronary syndrome: does every culprit lesion require revascularization? Curr Cardiol Rep 2010; 12: 330–337. PMID: 20425159 451. Brener SJ, Milford-Beland S, Roe MT, et al. American College of Cardiology National Cardiovascular Database Registry. Culpritonly or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J 2008; 155: 140–146. PMID: 18082505 452. Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culpritonly stenting? J Am Coll Cardiol 2007; 49: 849–854. PMID: 17320742 453. Sardella G, Lucisano L, Garbo R, et al. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J Am Coll Cardiol 2016; 67: 264–272. PMID: 26796390 454. Tonino PA, De Bruyne B, Pijls NH, et al. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213–224. PMID: 19144937 455. Bär FW, Verheugt FW, Col J, et al. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation 1992; 86: 131–137. PMID: 1617766 456. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393–1402. PMID: 22445239 457. Bønaa KH, Mannsverk J, Wiseth R, et al. NORSTENT Investigators. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. N Engl J Med 2016; 375: 1242–1252. PMID: 27572953 458. Singh M, Holmes DR, Garratt KN, et al. Changing Outcome of Percutaneous Intervention in Patients With Unstable Angina. J Am Coll Cardiol 1999; 33 Suppl: 31A. 459. Myler RK, Shaw RE, Stertzer SH, et al. Unstable angina and coronary angioplasty. Circulation 1990; 82(3 Suppl): II88–95. PMID: 2203565 460. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet 1998; 352: 673–681. PMID: 9728982 461. Marzocchi A, Piovaccari G, Marrozzini C, et al. Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol 1997; 79: 1314–1318. PMID: 9165149 462. Fox KA, Clayton TC, Damman P, et al. FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 2010; 55: 2435–2445. PMID: 20359842 463. Liistro F, Angioli P, Falsini G, et al. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart 2005; 91: 1284–1288. PMID: 15761051 464. Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005; 366: 914–920. PMID: 16154018 465. Lemos PA, Lee CH, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2003; 41: 2093–2099. PMID: 12798587 466. Valgimigli M, Campo G, Arcozzi C, et al. Two-year clinical

follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 2007; 50: 138–145. PMID: 17616297 467. Spaulding C, Henry P, Teiger E, et al. TYPHOON Investigators.

Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093–1104. PMID: 16971716 468. Menichelli M, Parma A, Pucci E, et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007; 49: 1924–1930. PMID: 17498576 469. van der Hoeven BL, Liem SS, Jukema JW, et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol 2008; 51: 618–626. PMID: 18261680 470. De Luca G, Valgimigli M, Spaulding C, et al. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. J Thromb Thrombolysis 2009; 28: 200–210. PMID: 19190859 471. Kandzari DE, Roe MT, Ohman EM, et al. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2005; 96: 750–755. PMID: 16169352 472. Vlaar PJ, Diercks GF, Svilaas T, et al. The feasibility and safety of routine thrombus aspiration in patients with non-ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2008; 72: 937–942. PMID: 19021272 473. V Korn H, Ohlow M, Donev S, et al. Export aspiration system in patients with acute coronary syndrome and visible thrombus provides no substantial benefit. Catheter Cardiovasc Interv 2007; 70: 35–42. PMID: 17585384 474. Ben-Dor I, Pichard AD, Waksman R. Combined mechanical and pharmacological approach to a thrombus-containing lesion. Catheter Cardiovasc Interv 2010; 75: 972–976. PMID: 20146325 475. Limbruno U, Ebert AG, Galli M. Filters to prevent distal embolization during coronary artery stenting: the risk of mousetrap. J Invasive Cardiol 2006; 18: E131–E133. PMID: 16723746 476. Shroyer AL, Grover FL, Edwards FH. 1995 coronary artery bypass risk model: The Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1998; 65: 879–884. PMID: 9527245 477. Shroyer AL, Plomondon ME, Grover FL, et al. The 1996 coronary artery bypass risk model: the Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1999; 67: 1205–1208. PMID: 10320291 478. O’Connor GT, Plume SK, Olmstead EM, et al. Northern New England Cardiovascular Disease Study Group. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Circulation 1992; 85: 2110–2118. PMID: 1591830 479. Yasuda K, Ayabe H, Ide H, et al. Thoracic and cardiovascular surgery in Japan during 1998. Annual report by the Japanese Association for Thoracic Surgery. Committee of Science. Jpn J Thorac Cardiovasc Surg 2000; 48: 401–415.  PMID: 10935337 480. Hirose H, Amano A, Yoshida S, et al. Surgical management of unstable patients in the evolving phase of acute myocardial infarction. Ann Thorac Surg 2000; 69: 425–428. PMID: 10735675 481. Montalescot G, Brieger D, Eagle KA, et al. GRACE Investigators. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J 2009; 30: 2308–2317. PMID: 19720640 482. Lazar HL, Jacobs AK, Aldea GS, et al. Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. Ann Thorac Surg 1997; 64: 1747–1752. PMID: 9436566 483. Kaul TK, Fields BL, Riggins SL, et al. Coronary artery bypass grafting within 30 days of an acute myocardial infarction. Ann Thorac Surg 1995; 59: 1169–1176. PMID: 7733715 484. Hochman JS, Boland J, Sleeper LA, et al. SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. Circulation 1995; 91: 873–881. PMID: 7828316 485. Rao V, Ivanov J, Weisel RD, et al. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996; 112: 38–51. PMID: 8691884 486. Dang NC, Topkara VK, Leacche M, et al. Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study. J Thorac Cardiovasc Surg 2005; 130: 693–698. PMID: 16153915 487. Nollert G, Amend J, Reichart B. Use of the internal mammary artery

as a graft in emergency coronary artery bypass grafting after failed PTCA. Thorac Cardiovasc Surg 1995; 43: 142–147. PMID: